SMMT — SUMMIT THERAPEUTICS INC

Ownership history in Squarepoint Ops LLC  ·  16 quarters on record

This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in SUMMIT THERAPEUTICS INC (SMMT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2025 Q2)
Avg. % of fund
0.0%
First filed
2020 Q4
Last filed
2025 Q4
Quarters held
16
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 715,410 -66,490 -8.5% 0.01% $12.5M $17.49
2025 Q3 ADDED 781,900 +662,600 +555.4% 0.02% $16.2M $20.66
2025 Q3 ADDED 119,300 +9,474 +8.6% 0.00% $2.5M $20.66
2025 Q3 REDUCED 109,826 -181,396 -62.3% 0.00% $2.3M $20.66
12 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    SMMT price (monthly, adj. close)

Other funds also holding SMMT

As of 2025 Q4 — sorted by position size

APEIRON CAPITAL Ltd 3Y 26.48% BAKER BROS. ADVISORS LP 3Y 7Y 3.73% Polymer Capital Management (HK) LTD 3.54% SECTORAL ASSET MANAGEMENT INC 3Y 7Y 1.12% Rock Springs Capital Management LP 3Y 7Y 0.64% QVT Financial LP 3Y 7Y 0.54% Capstone Capital Management Ltd 0.47% GRIFFIN ASSET MANAGEMENT, INC. 3Y 7Y 0.37% Affinity Asset Advisors, LLC 3Y 0.35% AXQ CAPITAL, LP 3Y 0.32%
← Back to Squarepoint Ops LLC Holdings